Arkolith/Insider Trading/RNAC/Form 4

Springer Timothy A

Director, 10% OwnerCartesian Therapeutics, Inc. (RNAC) · full profile →Form 4 · filed Jan 15, 2025
Net Buying
Open-Market Buys
$366K
Open-Market Sells
$0
Net Open-Market Flow
$366K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2025Buy(P)4K$18.00$72K8.5M
Jan 13, 2025Buy(P)8K$16.86$134K8.5M
Jan 13, 2025Buy(P)9K$17.78$160K8.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001453687-25-000047) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML